Lepu Biopharma Co., Ltd. (HKG:2157)

Lepu Biopharma Revenue

In the year 2025, Lepu Biopharma had annual revenue of 934.87M CNY with 154.18% growth. Lepu Biopharma had revenue of 468.93M in the half year ending December 31, 2025, with 553.11% growth.

• Revenue: 934.87M CNY
• Revenue Growth: +154.18%
• P/S Ratio: 7.84
• Revenue / Employee: 1.32M CNY
• Employees: 710
• Market Cap: 8.16B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	934.87M	567.08M	154.18%
Dec 31, 2024	367.79M	142.44M	63.21%
Dec 31, 2023	225.35M	209.78M	1,347.16%
Dec 31, 2022	15.57M	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 27, 2026

Data Sources Report a data error